METTL3 and metabolic dysfunction-associated steatotic liver disease: Thus, METTL3 was identified as a previously unrecognized suppressor of the NAFL-to-NASH transition.60 This study revealed that the function of METTL3 in NAFLD not only in enhancing the m6A modification pathway but also in inducing histone deacetylation.